Ann: AGM Presentation, page-38

"While I was embarrassing and stupid (thanks for your nice treatment): I did what I should have done in terms of sharing thoughts"

As far as credibility is concerned, you keep digging a bigger hole for yourself. And YES, you are 'embarrassing and stupid'.

First, you come on here, declaring yourself a 'newbie', even though you have been posting on HC for nearly 5 years - with your first post indicating that you were anything but a 'newbie' even then!

And, yes, your reference to Theranos (where their blood test product was in a category that required minimal FDA scrutiny) was stupid and irrelevant and, of course, only introduced as negative innuendo in order to unsettle the natives.

And now, you make arrogant ('may see a pop by gullible retail investors') and fluffed-up, holier than thou ('I did what I should have done in terms of sharing thoughts') posts based on poor and very inaccurate readings of the FSGS pipeline.

If you did your research intelligently - without giving away your thinly disguised strategy of loosening weak hands for your personal benefit - you would have discovered that:

1. VX-147 is only targeting a small proportion of FSGS sufferers (i.e. those with APOL1-medited FSGS or AMKD -which is only 1 of 36 known genetic causes of FSGS - and, further, does not include the non-genetic causes of FSGS)
2. VX-147 has not even completed recruitment for its Phase 2b trial and is therefore well over '6-12 months behind' DXB-200.

Why not just pay up now (when there is plenty of room for further growth) rather than play your half-baked and manipulative games for the purpose of acquiring cheaper shares?